Dr. Daniel Bauer, MD

• Pediatric Hematology & Oncology

• Pediatrics

*Healthgrades does not verify qualifications for medical specialties. Please verify your provider's specialty and qualifications directly with your provider and applicable medical board.

• Boston Children's Hospital/dana-farber Cancer Insitute, Pediatric Hematology/oncology

  Fellowship Hospital

• Boston Children's Hospital, Pediatrics

  Residency Hospital

• Boston Children's Hospital

  Internship Hospital

• University Of Pennslyvania

  Medical School

• University Of Pennsylvania

  Medical School, 2003

• Phage-assisted evolution of an adenine base editor with improved Cas domain compatibility and activity, 2020-03-16

• Transcription factors LRF and BCL11A independently repress expression of fetal hemoglobin, 2016-01-15

• Therapeutic adenine base editing of human hematopoietic stem cells, 2023-01-13

• Direct Promoter Repression by BCL11A Controls the Fetal to Adult Hemoglobin Switch, 2018-03-29

• DissectingELANEneutropenia pathogenicity by human HSC gene editing, 2021-01-28

• Combinatorial Assembly of Developmental Stage-Specific Enhancers Controls Gene Expression Programs during Human Erythropoiesis, 2012-10-04

• An APOBEC3A-Cas9 base editor with minimized bystander and off-target activities, 2018-07-30

• Human genetic diversity alters off-target outcomes of therapeutic gene editing, 2022-12-15

• Single-cell cloning of human T-cell lines reveals clonal variation in cell death responses to chemotherapeutics, 2019-06-12

• Forward genetic screen of human transposase genomic rearrangements, 2016-08-04

• Whole genome sequencing identifies structural variants contributing to hematologic traits in the NHLBI TOPMed program, 2022-12-08

• Transcription factor competition at the ?-globin promoters controls hemoglobin switching, 2021-03-01

• Update on fetal hemoglobin gene regulation in hemoglobinopathies, 2011-04-19

• Differentiation of NUT Midline Carcinoma by Epigenomic Reprogramming, 2011-03-29

• Functional footprinting of regulatory DNA, 2015-08-31

• Hemoglobin switching's surprise: the versatile transcription factor BCL11A is a master repressor of fetal hemoglobin, 2015-09-14

• Genome-wide CRISPR-Cas9 screen identifies leukemia-specific dependence on a pre-mRNA metabolic pathway regulated by DCPS, 2018-02-22

• Clinicopathologic Features and Long-Term Outcomes of NUT Midline Carcinoma, 2012-08-15

• Analyzing CRISPR genome editing experiments with CRISPResso, 2016-07-12

• Common variants in signaling transcription factor binding sites drive phenotypic variability in red blood cell traits, 2020-11-23

• Small molecule PAPD5 inhibitors restore telomerase activity in patient stem cells, 2020-04-21

• An erythroid enhancer ofBCL11Asubject to genetic variation determines fetal hemoglobin level, 2013-10-11

• Technical Considerations for the Use of CRISPR/Cas9 in Hematology Research, 2017-07-27

• The mTORC1/4E-BP pathway coordinates hemoglobin production with L-leucine availability, 2015-04-14

• Integrated design, execution, and analysis of arrayed and pooled CRISPR genome-editing experiments, 2018-04-12

• Functional interrogation of non-coding DNA through CRISPR genome editing, 2017-03-10

• Accurate and rapid analysis of genome editing data from nucleases and base editors with CRISPResso2, 2019-04-05

• Genome-wide association study of red blood cell traits in Hispanics/Latinos: The Hispanic Community Health Study/Study of Latinos, 2017-04-28

• Editing GWAS: experimental approaches to dissect and exploit disease-associated genetic variation, 2021-03-10

• Highly efficient therapeutic gene editing of human hematopoietic stem cells, 2019-03-25

• Intensive treatment and survival outcomes in NUT midline carcinoma (NMC) of the head and neck (HN), 2016-08-10

• Rational targeting of a NuRD subcomplex guided by comprehensive in situ mutagenesis, 2019-06-28

• Assessing and advancing the safety of CRISPR-Cas tools: from DNA to RNA editing, 2023-01-13

• Single-cell trajectories reconstruction, exploration and mapping of omics data with STREAM, 2019-04-23

• Transcription factor competition at the ?-globin promoters controls hemoglobin switching, 2021-05-28

• Epitope editing enables targeted immunotherapy of acute myeloid leukaemia, 2023-08-30

• ZNF410 represses fetal globin by singular control of CHD4, 2021-04-15

• BCL11Aenhancer dissection by Cas9-mediatedin situsaturating mutagenesis, 2015-09-16

• Variant-aware saturating mutagenesis using multiple Cas9 nucleases identifies regulatory elements at trait-associated loci, 2017-02-20

• CRISPR-SURF: discovering regulatory elements by deconvolution of CRISPR tiling screen data, 2019-06-24

• DNAJB1-PRKACAin HEK293T cells inducesLINC00473overexpression that depends on PKA signaling, 2022-02-15

• Therapeutic base editing of human hematopoietic stem cells, 2020-03-16

• Synthetic Lethality of Wnt Pathway Activation and Asparaginase in Drug-Resistant Acute Leukemias, 2019-04-15

• CRISPRO: identification of functional protein coding sequences based on genome editing dense mutagenesis, 2018-10-19

• CRISPR-suppressor scanning reveals a nonenzymatic role of LSD1 in AML, 2019-04-15

• Generation of Genomic Deletions in Mammalian Cell Lines via CRISPR/Cas9, 2014-01-03